Brand Name
Inotropin
Indications
Former 1st line treatment for shock to Inprove CO, support BP, and maintain renal function
MOA
Endogenous nonselective direct and indirect adrenergic and dopaminergic agonist
Lower dose (< 3 mcg/kg/min) activate D1 receptors to dilate renal, mesenteric, and splenic arterial blood vessels increasing Blood Flow, activate D2 receptors reducing NE release from pre and post ganglionic sympathetic neurons.
Higher doses > 10 mcg/kg/min: activate alpha-1 receptors increasing arterial pressure through arteriolar vasoconstriction
Renal perfusion dose
0.5-3 mcg/kg/min
CV stability dose
10-20 mcg/kg/min
Important note
Chronotropic and proarrythmic effects limit its usefulness in some pts, largely replaced by NE or fendoldopam